ACHM Clinic Accreditation Explained

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

The Undersea & Hyperbaric Medical Society (UHMS) sets the standards for hyperbaric oxygen therapy, publishing key documents like the 14th Edition of HBO Indications, which details recognized conditions for treatment.
The FDA recommends using UHMS-accredited hyperbaric facilities for treating specific illnesses, ensuring a higher standard of care.
Hyperbaric oxygen therapy is defined by the UHMS, with its definition appearing in both the 13th and 14th Editions of its Indications reports.
One specific condition, air or gas embolism, can occur from pulmonary barotrauma after an ascent of as little as one meter, highlighting the critical need for proper treatment guidelines.

The Undersea & Hyperbaric Medical Society (UHMS) plays a central role in establishing the standards for hyperbaric oxygen therapy (HBOT) clinics. This includes publishing comprehensive guides, such as the 14th Edition of its "Hyperbaric Oxygen Therapy Indications," which outlines conditions where HBOT is recognized as beneficial. The UHMS also provides an accreditation program for hyperbaric facilities, a program that the Food and Drug Administration (FDA) specifically recommends for treating certain illnesses. This recommendation from the FDA underscores the importance of choosing a UHMS-accredited facility for hyperbaric oxygen therapy. In fact, the UHMS defines hyperbaric oxygen in both its 13th and 14th Editions of "Hyperbaric Oxygen Therapy Indications," ensuring clarity and consistency across the field. Patients seeking HBOT should understand what UHMS accreditation means for their care.

What is ACHM Clinic Accreditation?

ACHM clinic accreditation refers to the process by which hyperbaric oxygen therapy facilities are evaluated and recognized for meeting specific standards of care and safety. While the acronym "ACHM" itself is not explicitly detailed in the provided research, the Undersea & Hyperbaric Medical Society (UHMS) is clearly identified as the leading authority for hyperbaric medicine accreditation. The UHMS offers a comprehensive Hyperbaric Facility Accreditation Program, which helps ensure that clinics provide high-quality care. The FDA officially recommends using UHMS-accredited hyperbaric facilities when treating specific illnesses, highlighting the importance of this recognition FDA recommendation for UHMS-accredited facilities.

The Role of the Undersea & Hyperbaric Medical Society

The Undersea & Hyperbaric Medical Society, located at 631 US Highway 1, Suite 307, North Palm Beach, FL 33408, USA, is a pivotal organization in the world of hyperbaric medicine. It is responsible for defining hyperbaric oxygen therapy itself and for setting the guidelines for its appropriate use. The UHMS publishes critical documents like the "Hyperbaric Oxygen Therapy Indications," now in its 14th Edition, which serves as the authoritative guide for healthcare providers on when and how to use HBOT. This publication covers everything from background information on hyperbaric oxygen to a detailed list of accepted indications for treatment.

The UHMS's accreditation program is designed to assess a facility's adherence to these established standards. This includes evaluating the facility's equipment, staff training, safety protocols, and overall operational procedures. Clinics that achieve UHMS accreditation demonstrate a commitment to patient safety and effective treatment outcomes, aligning with the best practices in hyperbaric medicine. The society's dedication to advancing the science and practice of undersea and hyperbaric medicine ensures that patients receive care based on the latest evidence and established guidelines.

Why Accreditation Matters for Patients

For patients considering hyperbaric oxygen therapy, choosing an accredited facility is crucial. Accreditation provides an assurance that the clinic operates under strict guidelines, has properly trained personnel, and uses appropriate equipment. This minimizes risks and maximizes the potential benefits of the therapy. The FDA's recommendation for UHMS-accredited facilities further reinforces this point, suggesting that these facilities are better equipped to provide safe and effective treatment for the specified conditions. Without such accreditation, patients might be exposed to facilities that do not meet the necessary safety and efficacy standards.

The accreditation process involves rigorous review, often including site visits and detailed documentation of procedures. This thorough evaluation helps to maintain a high level of quality across the industry. Patients can feel more confident knowing that their chosen clinic has undergone this scrutiny and meets the high benchmarks set by a respected medical society. The UHMS also publishes information on how facilities can prepare for accreditation workshops, indicating a structured and educational approach to improving hyperbaric medicine practices. This commitment to education and rigorous standards ultimately benefits the patient by ensuring access to reliable and safe care.

Understanding "Hyperbaric Oxygen: Definition"

The UHMS clearly defines hyperbaric oxygen in its publications. This definition is fundamental to understanding what HBOT entails and what standards clinics must meet. The 14th Edition of "Hyperbaric Oxygen Therapy Indications" includes a section specifically titled "Hyperbaric Oxygen: Definition," which outlines the parameters of the therapy. This definition typically involves breathing 100% oxygen at increased atmospheric pressure, usually in a specialized chamber. This controlled environment allows for a significant increase in the amount of oxygen dissolved in the blood plasma, which can then reach tissues that are hypoxic (oxygen-deprived). The precise definition ensures consistency in how the therapy is administered and studied, contributing to the evidence base that supports its use for various medical conditions.

Why is UHMS Accreditation Important for Hyperbaric Oxygen Therapy?

UHMS accreditation is important for hyperbaric oxygen therapy because it establishes a consistent standard of care and patient safety across facilities. The Undersea & Hyperbaric Medical Society is the recognized authority for setting the definitions and guidelines for HBOT, ensuring that treatments are administered effectively and safely. This accreditation process helps to ensure that clinics meet recognized guidelines for patient safety and treatment quality, which is critical for a specialized and potentially complex medical procedure.

Setting the Standards for Hyperbaric Oxygen Therapy

The UHMS is at the forefront of defining and standardizing hyperbaric oxygen therapy. Their comprehensive "Hyperbaric Oxygen Therapy Indications" document, now in its 14th Edition, serves as the definitive reference for approved uses of HBOT UHMS Hyperbaric Oxygen Therapy Indications, 14th Edition. This document outlines the background of hyperbaric oxygen, its precise definition, and the utilization review process for HBOT. It also details the procedure for accepting new indications, ensuring that any additions are based on robust scientific evidence. The UHMS's Hyperbaric Oxygen Therapy Committee, composed of experts in the field, is responsible for maintaining and updating these standards. This continuous review process ensures that the guidelines remain current with advances in medical science and research.

For example, the 13th Edition of the "Hyperbaric Oxygen Therapy Indications" also contained key sections on the background and definition of hyperbaric oxygen, demonstrating a consistent approach over time UHMS Hyperbaric Oxygen Therapy Indications, 13th Edition. This consistency is vital for both practitioners and patients, providing a stable framework for understanding and applying HBOT. The society's commitment to publishing these detailed reports means that there is a clear, evidence-based roadmap for safe and effective hyperbaric practice.

Ensuring Patient Safety and Quality of Treatment

Accreditation by the UHMS ensures that facilities adhere to strict safety protocols and deliver high-quality treatment. Hyperbaric oxygen therapy involves specialized equipment, including hyperbaric chambers, and requires trained personnel to operate them safely. There are different types of hyperbaric chambers, and each requires specific operational knowledge. The accreditation process evaluates a clinic's ability to manage the unique risks associated with hyperbaric environments, such as pressure changes and oxygen toxicity. This includes assessing the qualifications of the medical staff, the maintenance of the hyperbaric chambers, and the emergency procedures in place.

The UHMS's standards cover various aspects of clinic operation, from initial patient assessment to the actual delivery of therapy and post-treatment care. This holistic approach to quality assurance helps to protect patients from potential complications and ensures that they receive the maximum therapeutic benefit. The emphasis on evidence-based practice within the UHMS guidelines means that treatments are not just safe but also effective for the conditions they are used to treat. This rigor is especially important in a field where off-label uses of HBOT, not supported by evidence, can sometimes be promoted.

The Comprehensive List of Accepted Indications

One of the most significant contributions of the UHMS is its comprehensive list of accepted indications for hyperbaric oxygen therapy. This list, detailed in both the 13th and 14th Editions of their "Hyperbaric Oxygen Therapy Indications," specifies the medical conditions for which HBOT has proven efficacy. Having a clear, authoritative list helps healthcare providers make informed decisions about when to prescribe HBOT and helps patients understand if the therapy is appropriate for their condition. Without such a list, there would be widespread confusion and potential misuse of the therapy.

The process for adding new indications is also clearly defined by the UHMS, emphasizing a rigorous, evidence-based approach. This prevents unsubstantiated claims from entering mainstream practice and ensures that all approved indications are supported by scientific research. This commitment to evidence and safety is a cornerstone of why UHMS accreditation is so highly valued in the medical community and why the FDA recommends its accredited facilities. By adhering to these well-established indications, accredited clinics ensure that they are providing treatments that are not only safe but also clinically justified and effective.

What are the Accepted Indications for Hyperbaric Oxygen Therapy?

The accepted indications for hyperbaric oxygen therapy are a specific set of medical conditions for which the Undersea & Hyperbaric Medical Society (UHMS) has recognized HBOT as a beneficial treatment. These conditions are detailed in comprehensive publications like the "Hyperbaric Oxygen Therapy Indications," with the 14th Edition being the most recent authoritative guide. This document serves as a critical resource for healthcare providers, outlining the evidence-based uses of HBOT.

Detailed List of UHMS Approved Indications

The UHMS lists specific conditions where hyperbaric oxygen therapy is recognized as beneficial. The 14th Edition of "Hyperbaric Oxygen Therapy Indications" provides a detailed list, including conditions such as:

Air or Gas Embolism
Arterial Insufficiencies (including Central Retinal Artery Occlusion and Selected Problem Wounds)
Carbon Monoxide Poisoning
Clostridial Myonecrosis (Gas Gangrene)
Compromised Grafts and Flaps
Acute Traumatic Ischemias
Decompression Sickness
Delayed Radiation Injuries (Soft Tissue and Bony Necrosis)
Sudden Sensorineural Hearing Loss
Intracranial Abscess
Necrotizing Soft Tissue Infections
Refractory Osteomyelitis
Severe Anemia
Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns

This comprehensive list, found in Part I of the 14th Edition, covers a wide range of acute and chronic conditions where HBOT can significantly improve patient outcomes. For instance, the 13th Edition of the "Hyperbaric Oxygen Therapy Indications" also listed Air or Gas Embolism, Carbon Monoxide Poisoning, and Compromised Grafts and Flaps as primary indications, demonstrating continuity in recognized applications. The UHMS committee, chaired by Lindell K. Weaver MD for the 13th Edition, emphasizes that these indications are based on thorough review and scientific evidence.

The Importance of Evidence-Based Indications

The UHMS's focus on evidence-based indications is paramount. This means that each condition on the list has undergone rigorous scientific scrutiny to determine the efficacy and safety of HBOT as a treatment. The "Hyperbaric Oxygen Therapy Committee Report" for the 13th Edition, for example, highlights the responsibility of the publisher and editor to ensure that no suggested test or procedure is carried out "unless, in the reader’s judgment, its risk is justified." This statement underscores the commitment to patient safety and the necessity for independent verification of diagnoses and drug dosages due to rapid advances in medical sciences.

This careful approach ensures that HBOT is not used indiscriminately but rather applied in situations where there is clear medical benefit. For example, for conditions like Carbon Monoxide Poisoning, HBOT works by speeding up the removal of carbon monoxide from the blood, preventing further cellular damage. In the case of Delayed Radiation Injuries, HBOT promotes healing by increasing oxygen delivery to damaged tissues, stimulating new blood vessel formation. These mechanisms are well-understood and supported by clinical research.

How New Indications are Accepted

The UHMS has a structured process for the acceptance (addition) of new indications for hyperbaric oxygen therapy. This process, outlined in both the 13th and 14th Editions of the "Hyperbaric Oxygen Therapy Indications," ensures that any new proposed uses for HBOT are thoroughly vetted. This typically involves reviewing scientific literature, clinical trials, and expert consensus. The goal is to ensure that any expansion of HBOT's applications is backed by robust data, maintaining the integrity and credibility of the therapy. This rigorous acceptance process is crucial for distinguishing between established, effective treatments and experimental or unproven applications.

The UHMS also provides information on utilization review for hyperbaric oxygen therapy, further emphasizing the need for appropriate and justified use of the treatment. This review process helps to ensure that HBOT is only prescribed when it aligns with the accepted indications and when it is medically necessary. This level of oversight benefits both patients and the healthcare system by promoting responsible and effective medical practice.

How Does Hyperbaric Oxygen Therapy Treat Air or Gas Embolism?

Hyperbaric oxygen therapy (HBOT) treats air or gas embolism by physically shrinking gas bubbles and increasing oxygen delivery to oxygen-deprived tissues. Gas embolism occurs when gas bubbles enter arteries or veins, obstructing blood flow and causing tissue damage. HBOT helps to reduce the size of these bubbles and facilitates their reabsorption into the blood, where they can be harmlessly eliminated. This mechanism is crucial for rapidly reversing the effects of gas embolism, which can be life-threatening.

Understanding Air or Gas Embolism

Gas embolism is a serious condition that can arise from various medical procedures and activities, including diving. Richard E. Moon, in "Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism," describes it as the entry of gas bubbles into arteries or veins. Arterial gas embolism (AGE) was first identified in submarine escape training, where pulmonary barotrauma occurred during rapid ascent after breathing compressed gas at depth. Pulmonary barotrauma and gas embolism can happen even after an ascent of as little one meter if breath holding occurs. AGE has also been linked to normal ascent in divers with underlying lung conditions like bullous disease and asthma.

Beyond diving, pulmonary barotrauma and gas embolism can result from blast injuries, mechanical ventilation, penetrating chest trauma, chest tube placement, and bronchoscopy. Venous gas embolism (VGE) is common after compressed gas diving, though usually asymptomatic as bubbles are trapped by pulmonary capillaries. However, large volumes of VGE can cause cough, dyspnea, and pulmonary edema. If the pulmonary capillary network is overwhelmed, bubbles can enter the arterial circulation. VGE can also bypass the lungs and enter the left heart directly through an atrial septal defect or patent foramen ovale.

Diverse Causes of Gas Embolism

The causes of gas embolism extend far beyond diving. Accidental intravenous air injection is a known cause, as are cardiopulmonary bypass accidents, needle biopsy of the lung, and hemodialysis. Central venous catheter placement or disconnection, gastrointestinal endoscopy, and even hydrogen peroxide irrigation or ingestion can lead to gas embolism. Other procedures implicated include arthroscopy, cardiopulmonary resuscitation, percutaneous hepatic puncture, and even non-medical activities like blowing air into the vagina during orogenital sex or sexual intercourse after childbirth.

Gas embolism can also occur during surgical procedures where the site is under pressure, such as laparoscopy, transurethral surgery, vitrectomy, endoscopic vein harvesting, and hysteroscopy. Massive VGE can happen when air passively enters surgical wounds elevated above the heart, creating subatmospheric pressure in adjacent veins. This has been noted in sitting craniotomy, cesarean section, prostatectomy, spine surgery, hip replacement, liver resection, liver transplantation, and dental implant insertion. The diverse range of causes underscores the broad applicability of HBOT in treating this condition.

How HBOT Works for Gas Embolism

Hyperbaric oxygen therapy helps in two main ways. First, increasing the ambient pressure in the hyperbaric chamber physically shrinks the gas bubbles, reducing their obstructive effect and allowing blood flow to resume. This is an immediate mechanical effect. Second, breathing 100% oxygen at increased pressure creates a steep gradient for nitrogen to diffuse out of the bubbles and into the blood, where it can be exhaled. This process helps to dissolve the bubbles and eliminate the gas from the body.

Richard E. Moon notes that clinical deficits can occur after intra-arterial injection of only small volumes of air, while intravenous injection is often asymptomatic. Experimental animals have tolerated intravenous injection of up to 0.5-1 mL/kg. In humans, continuous IV infusion of oxygen at 10 mL/min has been tolerated, but 20 mL/min caused symptoms. This indicates that the volume and speed of gas entry are critical. HBOT's ability to rapidly decrease bubble size and promote gas elimination is vital, especially since injections of air are more likely to cause clinical abnormalities compared to constant infusions. The increased oxygen also helps to resuscitate tissues that have been deprived of oxygen due to the embolism, preventing further damage and promoting healing.

What Other Conditions Benefit from HBOT?

Beyond air or gas embolism, hyperbaric oxygen therapy (HBOT) is recognized by the Undersea & Hyperbaric Medical Society (UHMS) for its benefits in treating a variety of other medical conditions. These conditions range from acute injuries to chronic conditions, all of which can benefit from increased oxygen delivery to compromised tissues. The UHMS's 14th Edition of "Hyperbaric Oxygen Therapy Indications" provides a comprehensive list of these approved uses, ensuring that HBOT is applied where it has proven efficacy.

Addressing Arterial Insufficiencies and Problem Wounds

Hyperbaric oxygen therapy is particularly effective in treating arterial insufficiencies and enhancing the healing of selected problem wounds. One specific indication is Central Retinal Artery Occlusion, a condition where blood flow to the retina is blocked, potentially leading to sudden vision loss. HBOT can help by increasing oxygen delivery to the ischemic retina, potentially restoring function if treated promptly.

Another significant area is the enhancement of healing in selected problem wounds. These include diabetic foot ulcers, chronic non-healing wounds, and wounds complicated by infection or poor circulation. By saturating the blood with oxygen, HBOT promotes the growth of new blood vessels, stimulates fibroblast activity (cells that produce connective tissue), and enhances the activity of white blood cells, which are crucial for fighting infection. The 13th Edition of the "Hyperbaric Oxygen Therapy Indications" also includes "Enhancement of Healing in Selected Problem Wounds" as a key area, demonstrating a long-standing recognition of its benefits.

Treating Infections and Tissue Damage

HBOT plays a crucial role in treating certain severe infections and tissue damage. Clostridial Myonecrosis, commonly known as gas gangrene, is a rapidly spreading bacterial infection that produces gas in tissues. HBOT is an essential adjunctive treatment for gas gangrene because the high oxygen levels are toxic to the anaerobic bacteria causing the infection, effectively halting its progression and reducing tissue destruction.

Necrotizing Soft Tissue Infections, another group of severe bacterial infections, also benefit from HBOT. These infections can lead to widespread tissue death and require aggressive treatment, often including surgery and antibiotics. HBOT assists by improving oxygenation in compromised tissues, which enhances the body's immune response and the effectiveness of certain antibiotics. Similarly, Refractory Osteomyelitis, a persistent bone infection that does not respond to conventional treatments, can be improved with HBOT. The increased oxygen helps to kill bacteria and supports bone healing. See the necrotizing soft tissue infections evidence atlas for the full study-by-study evidence breakdown.

Supporting Grafts, Flaps, and Radiation Injuries

Compromised Grafts and Flaps, often used in reconstructive surgery, can fail if their blood supply is insufficient. HBOT can significantly improve the survival rate of these tissues by increasing oxygen delivery and promoting angiogenesis (new blood vessel formation). This is particularly important in cases where the tissue transfer might be at risk due to poor circulation. The 14th Edition of the UHMS indications clearly outlines the effect of hyperbaric oxygen on compromised grafts and flaps.

Delayed Radiation Injuries, which can affect soft tissue and bone (osteonecrosis) months or even years after radiation therapy, are also effectively treated with HBOT. Radiation can damage blood vessels and impair healing, leading to chronic pain, non-healing wounds, and bone death. HBOT helps by improving blood flow, stimulating tissue repair, and reducing inflammation in the irradiated areas. The UHMS report includes "Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research" as a dedicated chapter, emphasizing its importance.

Other Notable Indications

The UHMS also recognizes HBOT for several other conditions. Severe Anemia, where patients cannot receive blood transfusions, can be managed with HBOT by significantly increasing the amount of oxygen dissolved in the plasma, effectively compensating for the reduced red blood cell count. Sudden Sensorineural Hearing Loss, an acute loss of hearing without an identifiable cause, is another condition where HBOT can improve outcomes, likely by improving oxygenation to the inner ear structures. Intracranial Abscesses, collections of pus within the brain, can also benefit from HBOT as an adjunct to surgery and antibiotics, helping to resolve the infection. The role of HBOT for Acute Traumatic Ischemias and as an adjunctive therapy in the treatment of Thermal Burns further demonstrates its versatility in critical care settings. See the intracranial abscess evidence atlas for the full study-by-study evidence breakdown.

Are There Different Types of Hyperbaric Chambers?

Yes, there are different types of hyperbaric chambers used in facilities that provide hyperbaric oxygen therapy (HBOT). These chambers vary primarily in their capacity, design, and the way oxygen is delivered, but all aim to deliver oxygen at increased atmospheric pressure. The choice of chamber depends on factors such as the patient's condition, the type of treatment protocol, and the facility's specific setup. Understanding these differences can help patients and practitioners select the most appropriate environment for therapy.

Monoplace Chambers

Monoplace hyperbaric chambers are designed to treat a single patient at a time. These chambers are typically cylindrical, transparent acrylic tubes that allow the patient to lie down comfortably. The entire chamber is pressurized with 100% oxygen, meaning the patient breathes the therapeutic oxygen directly from the chamber environment. This design offers a private and often less intimidating experience for the patient. The transparency of the chamber allows medical staff to continuously monitor the patient visually during the treatment session.

One advantage of monoplace chambers is the direct delivery of 100% oxygen without the need for an oxygen mask or hood for the patient. This can be more comfortable for some individuals, especially those who might feel claustrophobic or have difficulty tolerating a mask. However, if a patient requires close medical intervention or has certain medical devices that cannot be exposed to 100% oxygen at pressure, a monoplace chamber might not be suitable. Facilities often choose monoplace chambers for their ease of operation and the ability to individualize treatment parameters for each patient.

Multiplace Chambers

Multiplace hyperbaric chambers are larger rooms or large cylindrical vessels that can accommodate multiple patients simultaneously, along with medical staff. In a multiplace chamber, the room is pressurized with compressed air, and patients breathe 100% oxygen through masks or hoods. This setup allows medical attendants to be inside the chamber with the patients, providing direct care, monitoring, and assistance throughout the treatment session. This can be particularly beneficial for critically ill patients, those who require continuous nursing care, or children who might need a parent present.

The ability for medical staff to enter the chamber with patients is a significant advantage of multiplace chambers, as it allows for immediate intervention if a patient experiences any issues. It also facilitates the management of complex cases where ongoing medical procedures or assessments are necessary during HBOT. Additionally, multiplace chambers can be more cost-effective for facilities that treat a high volume of patients, as multiple individuals can be treated in a single session. However, the requirement for patients to wear masks or hoods for oxygen delivery might be less comfortable for some compared to breathing ambient oxygen in a monoplace chamber.

Key Differences and Considerations

The primary differences between monoplace and multiplace chambers lie in their capacity, the pressurizing gas, and the method of oxygen delivery. Monoplace chambers are pressurized with 100% oxygen, and the patient breathes this directly. Multiplace chambers are pressurized with compressed air, and patients breathe 100% oxygen via a delivery system like a mask. Both types of chambers are designed to safely deliver oxygen at increased atmospheric pressure, which is the core principle of hyperbaric oxygen therapy.

The choice between chamber types often depends on the specific needs of the patient population served by a clinic. For instance, a facility specializing in acute decompression sickness or carbon monoxide poisoning might favor multiplace chambers due to the need for close monitoring and immediate intervention for potentially unstable patients. Clinics focusing on chronic wound care or delayed radiation injuries might find monoplace chambers more suitable for their stable patient population. Regardless of the type of chamber, UHMS accreditation ensures that the facility adheres to strict safety and operational standards for all its equipment and procedures. The goal remains consistent: to provide effective and safe hyperbaric oxygen therapy for approved indications.

Frequently Asked Questions

What does UHMS accreditation mean for a hyperbaric clinic?

UHMS accreditation signifies that a hyperbaric clinic meets the high standards set by the Undersea & Hyperbaric Medical Society for patient care, safety, and operational excellence. The FDA specifically recommends using UHMS-accredited hyperbaric facilities for treating specific illnesses, highlighting the importance of this recognition. It assures patients that the facility adheres to established guidelines and best practices in hyperbaric medicine.

How many recognized indications are there for hyperbaric oxygen therapy?

The Undersea & Hyperbaric Medical Society (UHMS) recognizes a comprehensive list of indications for hyperbaric oxygen therapy. The 14th Edition of "Hyperbaric Oxygen Therapy Indications" details over a dozen specific conditions where HBOT is considered beneficial, including air or gas embolism, carbon monoxide poisoning, and compromised grafts and flaps. This number reflects the extensive research and evidence supporting HBOT's efficacy for these conditions.

Can hyperbaric oxygen therapy treat conditions beyond those listed by UHMS?

While some clinics may offer hyperbaric oxygen therapy for conditions not on the UHMS's official list, these are considered "off-label" uses and may not have the same level of scientific evidence supporting their efficacy. The UHMS has a structured process for accepting new indications, ensuring that any additions are based on robust research. For example, the 13th Edition of the UHMS Indications also clearly outlined the process for the "Acceptance (Addition) of New Indications for Hyperbaric Oxygen Therapy."

What is the role of the FDA in hyperbaric oxygen therapy?

The FDA's role in hyperbaric oxygen therapy includes regulating hyperbaric chambers as medical devices and recommending UHMS-accredited facilities for the treatment of specific illnesses. While the FDA does not directly accredit clinics, its recommendation of UHMS-accredited facilities underscores the importance of adhering to recognized standards. The FDA's 510(k) Premarket Notification process ensures that hyperbaric chambers meet safety and effectiveness standards before they are marketed.

Where can I find the official list of hyperbaric oxygen therapy indications?

The official list of hyperbaric oxygen therapy indications can be found in the "Hyperbaric Oxygen Therapy Indications" publication by the Undersea & Hyperbaric Medical Society (UHMS). The most current version is the 14th Edition, which provides detailed information on each recognized condition, such as Air or Gas Embolism, and its treatment protocols. This document is the authoritative guide used by medical professionals in the field.